Treating with ACK1 inhibitor (R-9BMS) can affect the proliferation of TNBCs, and through the detection of tyrosine phosphorylation will provide help for the diagnosis, treatment, and prognosis of breast cancer. This evidence concerns the gene TNK2 and breast cancer.